CapsoVision, Inc (CV): Revenue
$13.55M
Year ended 2025-12-31
$13.89M
Trailing 12 months to 2026-06-30
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.55M | +15.3% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $11.76M | n/a | 2026-03-26, From 2024-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| CapsoVision, Inc (CV) | 2025-12-31 | $13.55M | +15.3% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $13.56M | +5.2% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $12.74M | +5.7% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $18.93M | +287.9% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $8.27M | -5.4% |
| Precision Optics Corporation, Inc. (POCI) | 2026-06-30 | $31.53M | +65.2% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $32.03M | +27.2% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $32.38M | +20.3% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.57M | +32.9% |
Compare CV, HYPR, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗